A Japan-based phase I trial of forigerimod.
Not yet recruiting
Phase of Trial: Phase I
Latest Information Update: 03 Nov 2011
At a glance
- Drugs Forigerimod (Primary)
- Indications Systemic lupus erythematosus
- Focus Adverse reactions; Therapeutic Use
- 03 Nov 2011 Status changed from planning to not yet recruiting.
- 16 Jun 2010 New trial record